Kara Bischoff1, Vivian Weinberg, Michael W Rabow. 1. Department of Medicine, University of California, San Francisco, 1849 Oak Street, Upper Unit, San Francisco, CA, 94117, USA, kara.bischoff@ucsf.edu.
Abstract
PURPOSE: Although outpatient palliative care clinics are increasingly common, evidence for their efficacy remains limited. METHODS: We conducted an observational study at the palliative care clinic of an academic cancer center to assess the association between palliative care co-management and symptoms and quality of life. Two hundred sixty-six adult outpatients were seen for a minimum of two palliative care visits within 120 days. A subset of 142 patients was seen for a third visit within 240 days. Patients completed a questionnaire containing validated symptom, quality of life, and spiritual wellbeing questions at each visit. RESULTS: The first follow-up visit was on average 41 days after the initial visit; the second follow-up visit was on average 81 days after the initial visit. Between the initial and first follow-up visits, there was significant improvement in pain (p < 0.001), fatigue (p < 0.001), depression (p < 0.001), anxiety (p < 0.001), quality of life (p = 0.002), and spiritual wellbeing (p < 0.001), but not nausea (p = 0.14). For the subset of patients seen for a second follow-up visit, the improvements in pain, fatigue, depression, anxiety, quality of life, and spiritual wellbeing persisted (p ≤ 0.005 for trend of each symptom). Patients had similar improvement regardless of their gender, age, ethnicity, disease stage, disease progression, and concurrent oncologic treatments. CONCLUSIONS: Palliative care was associated with significant improvement in nearly all the symptoms evaluated. A sustained change in symptoms was observed in the subset of patients seen for a second follow-up visit. Members of all subgroups improved.
PURPOSE: Although outpatient palliative care clinics are increasingly common, evidence for their efficacy remains limited. METHODS: We conducted an observational study at the palliative care clinic of an academic cancer center to assess the association between palliative care co-management and symptoms and quality of life. Two hundred sixty-six adult outpatients were seen for a minimum of two palliative care visits within 120 days. A subset of 142 patients was seen for a third visit within 240 days. Patients completed a questionnaire containing validated symptom, quality of life, and spiritual wellbeing questions at each visit. RESULTS: The first follow-up visit was on average 41 days after the initial visit; the second follow-up visit was on average 81 days after the initial visit. Between the initial and first follow-up visits, there was significant improvement in pain (p < 0.001), fatigue (p < 0.001), depression (p < 0.001), anxiety (p < 0.001), quality of life (p = 0.002), and spiritual wellbeing (p < 0.001), but not nausea (p = 0.14). For the subset of patients seen for a second follow-up visit, the improvements in pain, fatigue, depression, anxiety, quality of life, and spiritual wellbeing persisted (p ≤ 0.005 for trend of each symptom). Patients had similar improvement regardless of their gender, age, ethnicity, disease stage, disease progression, and concurrent oncologic treatments. CONCLUSIONS: Palliative care was associated with significant improvement in nearly all the symptoms evaluated. A sustained change in symptoms was observed in the subset of patients seen for a second follow-up visit. Members of all subgroups improved.
Authors: Karen E Steinhauser; Elizabeth C Clipp; Hayden B Bosworth; Maya McNeilly; Nicholas A Christakis; Corrine I Voils; James A Tulsky Journal: Palliat Support Care Date: 2004-03
Authors: David Hui; Ahmed Elsayem; Maxine De la Cruz; Ann Berger; Donna S Zhukovsky; Shana Palla; Avery Evans; Nada Fadul; J Lynn Palmer; Eduardo Bruera Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Matthew Follwell; Debika Burman; Lisa W Le; Kristina Wakimoto; Dori Seccareccia; John Bryson; Gary Rodin; Camilla Zimmermann Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Angelos P Kassianos; Myria Ioannou; Marianna Koutsantoni; Haris Charalambous Journal: Support Care Cancer Date: 2017-09-20 Impact factor: 3.603
Authors: Ryan D Nipp; Joseph A Greer; Areej El-Jawahri; Lara Traeger; Emily R Gallagher; Elyse R Park; Vicki A Jackson; William F Pirl; Jennifer S Temel Journal: Oncologist Date: 2015-11-30
Authors: Brook Calton; William Patrick Shibley; Eve Cohen; Steven Z Pantilat; Michael W Rabow; David L O'Riordan; Kara E Bischoff Journal: Palliat Med Rep Date: 2020-12-28